2019
DOI: 10.1016/j.jaci.2019.03.034
|View full text |Cite
|
Sign up to set email alerts
|

Bagels and LOX in patients with eosinophilic esophagitis

Abstract: eron; has an equity interest in the first 3 listed; receives royalties from reslizumab (Teva Pharmaceuticals), PEESSv2 (Mapi Research Trust), and UpToDate; and is an inventor of patents owned by Cincinnati Children's. The rest of the authors declare that they have no relevant conflicts of interest.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 11 publications
0
0
0
Order By: Relevance